Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Abstract

Summary Background Stroke is a leading cause of mortality and disability worldwide and the economic costs of treatment and post-stroke care are substantial. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic, comparable method of quantifying health loss by disease, age, sex, year, and location to provide information to health systems and policy makers on more than 300 causes of disease and injury, including stroke. The results presented here are the estimates of burden due to overall stroke and ischaemic and haemorrhagic stroke from GBD 2016. Methods We report estimates and corresponding uncertainty intervals (UIs), from 1990 to 2016, for incidence, prevalence, deaths, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs). DALYs were generated by summing YLLs and YLDs. Cause-specific mortality was estimated using an ensemble modelling process with vital registration and verbal autopsy data as inputs. Non-fatal estimates were generated using Bayesian meta-regression incorporating data from registries, scientific literature, administrative records, and surveys. The Socio-demographic Index (SDI), a summary indicator generated using educational attainment, lagged distributed income, and total fertility rate, was used to group countries into quintiles. Findings In 2016, there were 5·5 million (95% UI 5·3 to 5·7) deaths and 116·4 million (111·4 to 121·4) DALYs due to stroke. The global age-standardised mortality rate decreased by 36·2% (−39·3 to −33·6) from 1990 to 2016, with decreases in all SDI quintiles. Over the same period, the global age-standardised DALY rate declined by 34·2% (−37·2 to −31·5), also with decreases in all SDI quintiles. There were 13·7 million (12·7 to 14·7) new stroke cases in 2016. Global age-standardised incidence declined by 8·1% (−10·7 to −5·5) from 1990 to 2016 and decreased in all SDI quintiles except the middle SDI group. There were 80·1 million (74·1 to 86·3) prevalent cases of stroke globally in 2016; 41·1 million (38·0 to 44·3) in women and 39·0 million (36·1 to 42·1) in men. Interpretation Although age-standardised mortality rates have decreased sharply from 1990 to 2016, the decrease in age-standardised incidence has been less steep, indicating that the burden of stroke is likely to remain high. Planned updates to future GBD iterations include generating separate estimates for subarachnoid haemorrhage and intracerebral haemorrhage, generating estimates of transient ischaemic attack, and including atrial fibrillation as a risk factor. Funding Bill & Melinda Gates Foundation

Evaluating the effects of alcohol and tobacco use on cardiovascular disease using multivariable Mendelian randomization

“…Failing to replicate the instrumental variable estimates Millwood et al 2019 found among participants in the China Kadoorie Biobank sample supports the hypothesized differential effect of alcohol consumption on CVD risk across ethnic backgrounds 14,39 . East Asia has the highest prevalence of stroke worldwide 40 , and generally lower alcohol consumption behaviors than European countrie. 3 .…”

Sex Differences in Long-Term Mortality and Functional Outcome After Rehabilitation in Patients With Severe Stroke

“…Stroke is a leading cause of death and disability worldwide (1). According to the most recent report from the Global Burden of Disease Stroke Collaboration, there were 1·03 million incident strokes in Western Europe and 0·81 in North America in 2016 (1).…”

“…Stroke is a leading cause of death and disability worldwide (1). According to the most recent report from the Global Burden of Disease Stroke Collaboration, there were 1·03 million incident strokes in Western Europe and 0·81 in North America in 2016 (1). Despite a substantial decline in stroke mortality in recent decades, stroke is the second leading cause of cardiovascular death worldwide (2).…”

Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke

“…Stroke is a leading cause of death worldwide and the leading cause of permanent disability 1,2 . About 80% of stroke cases are of ischaemic origin 3 . The risk of ischaemic stroke is determined by a complex interplay of genetic and environmental factors partly acting through modifiable risk factors such as hypertension and diabetes.…”